145 related articles for article (PubMed ID: 8974456)
1. Synthesis and antiviral activity of peptide-oligonucleotide conjugates prepared by using N alpha-(bromoacetyl)peptides.
Arar K; Aubertin AM; Roche AC; Monsigny M; Mayer R
Bioconjug Chem; 1995; 6(5):573-7. PubMed ID: 8974456
[TBL] [Abstract][Full Text] [Related]
2. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.
Bongartz JP; Aubertin AM; Milhaud PG; Lebleu B
Nucleic Acids Res; 1994 Nov; 22(22):4681-8. PubMed ID: 7984418
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates.
Reed MW; Fraga D; Schwartz DE; Scholler J; Hinrichsen RD
Bioconjug Chem; 1995; 6(1):101-8. PubMed ID: 7711095
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes.
Zelphati O; Wagner E; Leserman L
Antiviral Res; 1994 Sep; 25(1):13-25. PubMed ID: 7811058
[TBL] [Abstract][Full Text] [Related]
5. Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif.
Pichon C; Arar K; Stewart AJ; Dodon MD; Gazzolo L; Courtoy PJ; Mayer R; Monsigny M; Roche AC
Mol Pharmacol; 1997 Mar; 51(3):431-8. PubMed ID: 9058598
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of antisense oligodeoxyribonucleotides and their anti-HIV activity.
Gug-Kim S; Suzuki Y; Nakashima H; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1991; (25):103-4. PubMed ID: 1842040
[No Abstract] [Full Text] [Related]
7. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides.
Soukchareun S; Tregear GW; Haralambidis J
Bioconjug Chem; 1995; 6(1):43-53. PubMed ID: 7711103
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of seven oligonucleotide analogues as potential antisense agents.
Morvan F; Porumb H; Degols G; Lefebvre I; Pompon A; Sproat BS; Rayner B; Malvy C; Lebleu B; Imbach JL
J Med Chem; 1993 Jan; 36(2):280-7. PubMed ID: 8423598
[TBL] [Abstract][Full Text] [Related]
10. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.
Tang JY; Temsamani J; Agrawal S
Nucleic Acids Res; 1993 Jun; 21(11):2729-35. PubMed ID: 8392706
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N alpha-(tert-butoxycarbonyl)-N epsilon-[N-(bromoacetyl)-beta-alanyl]-L-lysine: its use in peptide synthesis for placing a bromoacetyl cross-linking function at any desired sequence position.
Inman JK; Highet PF; Kolodny N; Robey FA
Bioconjug Chem; 1991; 2(6):458-63. PubMed ID: 1805944
[TBL] [Abstract][Full Text] [Related]
12. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
13. Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates.
Bonfils E; Depierreux C; Midoux P; Thuong NT; Monsigny M; Roche AC
Nucleic Acids Res; 1992 Sep; 20(17):4621-9. PubMed ID: 1408764
[TBL] [Abstract][Full Text] [Related]
14. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates.
Astriab-Fisher A; Sergueev DS; Fisher M; Shaw BR; Juliano RL
Biochem Pharmacol; 2000 Jul; 60(1):83-90. PubMed ID: 10807948
[TBL] [Abstract][Full Text] [Related]
15. The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach.
Sumbatyan NV; Mandrugin VA; Deroussent A; Bertrand JR; Majer Z; Malvy C; Korshunova GA; Hollosi M; Gottikh MB
Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1911-27. PubMed ID: 15628748
[TBL] [Abstract][Full Text] [Related]
16. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
Grijalvo S; Terrazas M; Aviñó A; Eritja R
Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
[TBL] [Abstract][Full Text] [Related]
17. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents.
Zatsepin TS; Turner JJ; Oretskaya TS; Gait MJ
Curr Pharm Des; 2005; 11(28):3639-54. PubMed ID: 16305500
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-influenza virus-A activity of circular dumbbell RNA DNA chimeric oligonucleotides.
Abe T; Hatta T; Yamakawa H; Takai K; Yokota T; Takaku H
Nucleic Acids Symp Ser; 1997; (37):219-20. PubMed ID: 9586078
[TBL] [Abstract][Full Text] [Related]
20. Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.
Wang C; Shi W; Cai L; Lu L; Yu F; Wang Q; Jiang X; Xu X; Wang K; Xu L; Jiang S; Liu K
J Antimicrob Chemother; 2014 Jun; 69(6):1537-45. PubMed ID: 24500189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
